Analytical Data
-
Gene name
BCL2L15
- Application
-
Alternative Names
AC124698.1; B2L15_HUMAN; Bcl-2-like protein 15; Bcl2-L-15; BCL2-like 15; Bcl2l15; Bfk; C1orf178; FLJ22588; Gm566; Pro apoptotic Bcl 2 protein
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5TBC7
-
Expression Region
1-163aa
-
Molecular Weight
44.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BCL2L15, also known as BCL2-like 15, is a member of the B-cell lymphoma 2 (BCL-2) family of proteins, which are primarily involved in regulating apoptosis, the process of programmed cell death crucial for maintaining cellular homeostasis and immunity. Research on BCL2L15 has gained importance due to its potential role in various biological processes and diseases, particularly in hematopoietic cells. This protein is thought to function as both an anti-apoptotic factor and a regulator of cell survival, thereby influencing the development and function of lymphocytes. Studies have shown that BCL2L15 may play a critical role in modulating immune responses and could be implicated in the pathogenesis of certain cancers and autoimmune disorders. Investigating the recombinant expression of BCL2L15 not only enables a better understanding of its molecular mechanisms but also holds promise for therapeutic applications, especially in designing targeted treatments that could manipulate apoptotic pathways. As such, the generation and characterization of BCL2L15 recombinant proteins are essential for elucidating its functions and interactions within cellular contexts, paving the way for novel biomedical approaches.
